Despite the dramatic improvement in viral eradication rates that has been reached with direct antiviral agents (DAAs), the real benefit of viral eradication after DAAs on hepatocellular carcinoma (HCC) development is still controversial.
Titolo: | Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals |
Autori: | |
Data di pubblicazione: | 2019 |
Rivista: | |
Abstract: | Despite the dramatic improvement in viral eradication rates that has been reached with direct antiviral agents (DAAs), the real benefit of viral eradication after DAAs on hepatocellular carcinoma (HCC) development is still controversial. |
Handle: | http://hdl.handle.net/11699/7599 |
Appare nelle tipologie: | 1.1 Articolo in rivista |
File in questo prodotto:
File | Descrizione | Tipologia | Licenza | |
---|---|---|---|---|
2018_DLD_HCC DAA cirrhosis.pdf | Versione Editoriale (PDF) | Copyright dell'editore | Administrator Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.